HOME >> MEDICINE >> NEWS
Unexpected target may unlock the door to fighting sepsis

Ann Arbor---Researchers at the University of Michigan and the University of Freiberg in Germany have demonstrated that blocking a substance the body normally produces to help fight bacteria shows great promise in animal studies as a potential treatment for the highly lethal disease, sepsis.

The findings are published in the July 1999 issue of Nature Medicine.

Sepsis is a bacterial infection of the blood or body tissues that kills half of the hundreds of thousands of people who get the disease each year in the United States.

Investigators found that when they blocked C5a, a protein product that is normally activated by the immune system, they were able to provide a significant degree of protection in sepsis-induced rats. C5a is a product of the mammalian complement system---a complex system of proteins and plasma that has powerful immune functions. C5a normally binds to certain white blood cells, called neutrophils, stimulating them to kill bacteria.

Earlier studies had shown that in sepsis an excess of C5a is produced, causing the neutrophils to become overstimulated and paralyzing many of their defensive functions. In essence, sepsis causes the body's own immune system to disarm its ability to fight the disease.

Researchers, led by Peter A. Ward, M.D., chair of the Department of Pathology in the University of Michigan Health System, found that septic rats injected with an immunoglobulin (IgG) antibody against C5a had powerful protection against sepsis. In the group of rats treated with the antibody against C5a, more than half survived. By contrast, in a second group treated with standard immunoglobulin, only 5 percent survived.

"This study reveals that in experimental sepsis, the system that produces protective mediators is overstimulated, leading to profoundly harmful consequences," says Ward. "If this is also the case in humans with sepsis, there could be obvious implications for a new therapeutic approach for the treatment of sepsis."
'"/>

Contact: Peter Barkey
pbarkey@umich.edu
734-764-2220
University of Michigan
29-Jun-1999


Page: 1 2 3

Related medicine news :

1. Unexpected benefit seen in treating HER-2 breast cancer with new preoperative drug combo
2. Unexpected similarities between raindrops and proteins
3. NHS target driven culture is failing patients
4. First mouse model for multiple system atrophy points to new treatment targets for brain diseases
5. NHS stop-smoking services are insufficient to deliver national smoking targets
6. Tumor-targeted immune cells cure prostate cancer in mice without causing systemic immune suppression
7. Potential drug target for treating cocaine abuse found
8. NHS Trusts meeting government target on stroke units in name only
9. Inflammatory cells highly promising target in NF 1
10. T cells target HIV in a relationship on the rebound
11. A site for sore eyes: New target for allergies found under the eyelid

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2020)... ... August 31, 2020 , ... ... organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community ... today announced the 10th Anniversary of Blood Cancer Awareness Month (BCAM) and its ...
(Date:8/31/2020)... ... 31, 2020 , ... Genesis Chiropractic Software and Billing ... launch of its integrated, HIPAA compliant, telehealth solution, available to US-based clients immediately. ... 90 seconds. , According to the U.S. Department of Health & Human ...
(Date:8/31/2020)... ... 31, 2020 , ... A Cure for Covid-19 “PTS” with Mediation & Hypnosis , At ... a state of panic, experiencing deep anxiety, immense stress, and right now are needing serious ... when most people on the planet are experiencing a great degree of emotional discomfort, be ...
(Date:8/29/2020)... , ... August 29, 2020 , ... When professor and ... with greater ease than most people would. Rather than become melancholic, however, he put ... advice on achieving one’s dreams. Randy Pausch took a negative situation and turned it ...
(Date:8/28/2020)... ... 28, 2020 , ... With in-person gluten-free events being canceled ... the specialty-diet community connect with great, gluten-free brands. At the Online Nourished ... with brands & watch over 50 educational classes... all online from the comfort ...
Breaking Medicine News(10 mins):
(Date:8/26/2020)... ... , ... AseptiScope, a privately funded San Diego, California based, clinical innovation company, ... , “AseptiScope is pleased to receive this recognition,” said Kelly Powers, AseptiScope ... their hands, goggles on their eyes, covers on their shoes, and gowns on their ...
(Date:8/26/2020)... ... August 26, 2020 , ... ... entered into definitive agreement to acquire ProCE, a nationally recognized provider of ... technicians. , CEA represents a growing alliance of CME/CE and service ...
(Date:8/26/2020)... (PRWEB) , ... August 26, 2020 , ... Hero ... a target goal of 115 million 3 ply surgical disposable face masks and N95 ... is in direct response to the challenge that most Americans are facing in trying ...
Breaking Medicine Technology:
Cached News: